EUVIMEDEUVIMED entdecken
Crossref

Anti-Diabetic Drug Induced Bone Loss in Diabetic Rats and Strategy to Prevent It

Krishnaraju Venkatesan, Rajalakshimi Vasudevan, Kumarappan Chidambaram, Kumar Venkatesan, Ester Mary Pappiya, Noohu Abdulla Khan, Sirajudeen Shaik Alavudeen, Vigneshwaran Easwaran, Premalatha Paulsamy, R.Natarajan, Kalpana Krishnaraju

IAR Journal of Pharmacy · 30.08.2021 · 2 (2) · 1-4

DOI: 10.47310/iarjp.2021.v02i02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IAR Journal of Pharmacy, online erschienen am 30.08.2021. Verfasst von Krishnaraju Venkatesan und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both glucose and metabolism and bone mass are controlled by the peroxisome proliferator-activated receptor-gamma (PPAR gamma). Recent data shows that anti diabetic thiazolidinediones (Rosiglitazone) have undesirable bone effects when used to modulate PPAR gamma activation. Psoraleae Fructus (FP) is the spicy and slightly bitter dried and ripe fruit of the leguminous plant Psoralea corylifolia L. It has been found to have a substantial anti-osteoporosis impact by increasing osteogenesis, decreasing adipogenesis and inhibiting osteoclastogenesis. The objective of this trial was to investigate if Psoraleae Fructus might help prevent bone loss caused by the drug rosiglitazone (RSG). Streptozotocin was used to induce diabetes. Wistar albino rats were put into five groups of six rats each: vehicle treatment, Streptozotocin (diabetes) group, Psoraleae Fructus group, Rosiglitazone and Rosiglitazone + Psoraleae Fructus group and Rosiglitazone +Psoraleae Fructus group. Each medication was given by gastric gavage once a day for 35 days. The bone mineral density (BMD) and haemoglobin A1c (HbA1c) levels were tested at the conclusion of the therapy period. BMD of the femur and lumbar vertebrae was assessed by dual-energy X-ray absorptiometry at the conclusion of the trial (DXA). Serum glucose and glycosylated haemoglobin serum were also tested. Both alone and in combination, Psoraleae Fructus and RSG significantly reduced elevated blood glucose levels. RSG treatment significantly decreased HBA1C levels when compared to the positive control. RSG and Psoraleae Fructus together significantly decreased blood glucose and HBA1C levels. The effects of RSG on BMD in the femur and lumbar vertebrae were unfavourable, while the benefits of Psoraleae Fructus treatment were considerably improved. Psoraleae Fructus supplementation in diabetic individuals using RSG may be an effective way to reduce RSG-induced bone loss, according to this study.

Zitieren

APA

Venkatesan, K., Vasudevan, R., Chidambaram, K., Venkatesan, K., Pappiya, E. M., Khan, N. A., Alavudeen, S. S., Easwaran, V., Paulsamy, P., R.Natarajan, & Krishnaraju, K. (2021). Anti-Diabetic Drug Induced Bone Loss in Diabetic Rats and Strategy to Prevent It. IAR Journal of Pharmacy, 2(2), 1-4. https://doi.org/10.47310/iarjp.2021.v02i02.001

Vancouver

Venkatesan K, Vasudevan R, Chidambaram K, Venkatesan K, Pappiya EM, Khan NA, et al. Anti-Diabetic Drug Induced Bone Loss in Diabetic Rats and Strategy to Prevent It. IAR Journal of Pharmacy. 2021;2(2):1-4. doi:10.47310/iarjp.2021.v02i02.001

BibTeX
@article{Venkatesan2021,
  author = {Venkatesan, Krishnaraju and Vasudevan, Rajalakshimi and Chidambaram, Kumarappan and Venkatesan, Kumar and Pappiya, Ester Mary and Khan, Noohu Abdulla and Alavudeen, Sirajudeen Shaik and Easwaran, Vigneshwaran and Paulsamy, Premalatha and R.Natarajan and Krishnaraju, Kalpana},
  title = {Anti-Diabetic Drug Induced Bone Loss in Diabetic Rats and Strategy to Prevent It},
  journal = {IAR Journal of Pharmacy},
  year = {2021},
  volume = {2},
  number = {2},
  pages = {1--4},
  doi = {10.47310/iarjp.2021.v02i02.001}
}
Kostenlos starten →